Courtney J. Wright

This study shows pregnancy alters sleep-wake patterns and reduces kynurenine-induced REM sleep disruption in female rats, suggesting KP metabolism influences maternal sleep.

This study shows that maternal sleep fragmentation and inflammation increase fetal brain kynurenic acid, linking sleep disruption to neurodevelopmental risks.

This study investigates how time of day affects kynurenic acid (KYNA) synthesis and inhibition in rats, showing phase-dependent changes in KYNA levels and KAT II enzyme activity.

The paper investigates how inhibiting kynurenine aminotransferase II (KAT II) affects sleep disturbances caused by kynurenine in rats.

This study shows that inhibiting KAT II reduces KYNA levels, improving sleep quality in rats exposed to embryonic kynurenine and in controls.